CBD Health Foods Ltd, trading as BRITISH CANNABIS™, is pleased to announce that it has entered into an exclusive Trademark & Know-How License Agreement (Agreement) with Elixinol Wellness Limited (Elixinol) (ASX:EXL; OTCQB:ELLXF), the wholly owned subsidiary of Elixinol Wellness (Corporate Services) Pty Ltd, to sell CBD products across the UK.
Given the complex and ongoing developments with the regulatory environment in the UK and given Elixinol’s strategic focus on driving profitability, Elixinol made the considered decision in 2021 to cease trading in the UK and EU markets and instead move to an indirect route to market by seeking a licensing partner in the UK.
The Elixinol and BRITISH CANNABIS™ Agreement enables Elixinol’s strong brand to still be distributed in the UK, whilst handing over the cost and expertise for its UK operations.
The appointment of BRITISH CANNABIS™ as the sole and exclusive Licensee of Elixinol-branded products in the UK, for a three-year term, marks a pivotal agreement in the course of the UK cannabinoid market. Both parties are in the early stages of market planning, which include renewed support of existing Elixinol sales channels, key retail customers and consumers. The shared aim is to improve revenues across the board, whilst building on the legacy set by Elixinol’s founders over 10 years ago, ensuring a continued execution of Elixinol’s global strategy.
Established in 2015, BRITISH CANNABIS™ is the largest independently owned, producer, manufacturer and distributor of legal cannabis-derived products in the UK. It has a suite of successful branded flagship products, along with a range of white label brands Powered by BRITISH CANNABIS™. With a focus on innovation, quality, accuracy and compliance that has backed products from this UK cannabis industry original for over 6 years, this focus now looks set to support the dynamic range of wellness solutions at Elixinol.
BRITISH CANNABIS™ CEO, Tom Whettem, commented
This document was authorised to be given to the ASX by the Board of the Company. Investor relations please contact: Ron Dufficy | Global CFO firstname.lastname@example.org
Elixinol Wellness Limited (ASX:EXL; OTCQB:ELLXF) is a global leader in the hemp industry, innovating, marketing and selling hemp derived nutraceutical, cosmetic and food products. The Company’s simplified business model is focusing on:
BRITISH CANNABIS™ - A UK CBD Industry Original
BRITISH CANNABIS™ is the largest producer, manufacturer, and distributor of legal cannabis-derived products in the UK. They own and operate a unique extraction and purification facility in England and provide analytical testing, bulk extracts and white label products to the UK market leading brands.